Published in J Surg Oncol on August 01, 2008
Helicobacter pylori protein-specific antibodies and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2013) 2.01
Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer. World J Surg (2010) 1.65
Second primary cancers in patients with gastric cancer. Radiol Oncol (2010) 0.91
Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up study. BMC Cancer (2012) 0.90
Metachronous pancreatic head ductal carcinoma three years after resection of gallbladder cancer. Int J Clin Exp Med (2013) 0.90
Incidental colonic 18F-fluorodeoxyglucose uptake: do we need colonoscopy for patients with focal uptake confined to the left-sided colon? Dig Dis Sci (2012) 0.88
Duodenal stump cancer after Billroth-II distal gastrectomy for gastric cancer. Gastric Cancer (2009) 0.88
Metachronous double primary cancer after diagnosis of gastric cancer. Cancer Res Treat (2012) 0.88
Clinical significance of colonoscopy in patients with upper gastrointestinal polyps and neoplasms: a meta-analysis. PLoS One (2014) 0.85
Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer. BMC Cancer (2013) 0.83
Metachronous bile duct cancer nine years after resection of gallbladder cancer. World J Gastroenterol (2009) 0.83
Is colonoscopic screening necessary for patients with gastric adenoma or cancer? Dig Dis Sci (2013) 0.82
Multiple primary malignancies involving primary sporadic colorectal cancer in Japan: incidence of gastric cancer with colorectal cancer patients may be higher than previously recognized. World J Surg Oncol (2015) 0.82
Multiple primary malignancies involving colorectal cancer--clinical characteristics and prognosis with reference to surveillance. Langenbecks Arch Surg (2009) 0.81
Clinical features of second primary cancers arising in early gastric cancer patients after endoscopic resection. World J Gastroenterol (2015) 0.80
Additional gastrectomy after endoscopic submucosal dissection for early gastric cancer patients with comorbidities. Int J Surg Oncol (2012) 0.80
Should a colonoscopy be recommended for healthy individuals with increased carcinoembryonic antigen levels? A case-control study. Dig Dis Sci (2011) 0.77
The value of preoperative screening colonoscopies in patients with biliary tract cancer. J Gastroenterol (2015) 0.77
Synchronous Double Malignant Tumors Consisting of Stomach and Hodgkin's Lymphoma with Collision between Gastric Adenocarcinoma and Hodgkin's Lymphoma in the Stomach. Case Rep Gastroenterol (2012) 0.76
The synchronous prevalence of colorectal neoplasms in patients with stomach cancer. J Korean Soc Coloproctol (2011) 0.75
Concurrent robot-assisted distal gastrectomy and partial nephrectomy for synchronous early gastric cancer and renal cell carcinoma: an initial experience. J Gastric Cancer (2014) 0.75
Synchronous and Metachronous Colon Cancers in Patients with Gastric Cancer: Report of 2 Cases. Case Rep Oncol (2016) 0.75
Effect of Previous Gastrectomy on the Performance of Postoperative Colonoscopy. J Gastric Cancer (2016) 0.75
Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study. World J Gastroenterol (2014) 0.75
Diagnostic accuracy of 18F-FDG PET/CT for detecting synchronous advanced colorectal neoplasia in patients with gastric cancer. Medicine (Baltimore) (2016) 0.75
A complete response to S-1 plus cis-diamminedichloroplatinum in advanced-stage esophageal and gastric adenocarcinoma: a case report. World J Surg Oncol (2012) 0.75
Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients? Gastric Cancer (2015) 0.75
Is Colonoscopic Screening Necessary for Patients Younger than 50 Years with Gastric Adenoma or Cancer? J Korean Med Sci (2017) 0.75
Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan. Gastric Cancer (2015) 0.75
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet (2012) 6.83
Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg (2010) 4.89
Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study. J Clin Oncol (2014) 4.79
Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation (2005) 3.54
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res (2009) 3.44
Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification. Ann Surg (2012) 3.15
The impact of comorbidity on surgical outcomes in laparoscopy-assisted distal gastrectomy: a retrospective analysis of multicenter results. Ann Surg (2008) 2.33
Comparative study of laparoscopy-assisted distal gastrectomy and open distal gastrectomy. J Am Coll Surg (2006) 2.23
Gastric cancer in Korea. Gastric Cancer (2002) 2.17
Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol (2013) 2.16
Mature chief cells are cryptic progenitors for metaplasia in the stomach. Gastroenterology (2010) 2.02
Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging. Ann Surg (2012) 1.96
Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol (2005) 1.95
Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol (2003) 1.86
Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective study. Surg Endosc (2011) 1.85
Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. Cancer Res (2010) 1.82
Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol (2002) 1.82
Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer (1998) 1.79
Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Liver Transpl (2009) 1.79
Electrospinning of collagen nanofibers: effects on the behavior of normal human keratinocytes and early-stage wound healing. Biomaterials (2005) 1.76
Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study. Cancer Res Treat (2012) 1.76
Analysis of long-term survivors after surgical resection for pancreatic cancer. Pancreas (2006) 1.72
Three-quarters of right liver donors experienced postoperative complications. Liver Transpl (2007) 1.70
Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer. Gastroenterology (2010) 1.64
Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology (2009) 1.64
An artificial vascular graft is a useful interpositional material for drainage of the right anterior section in living donor liver transplantation. Liver Transpl (2007) 1.61
Low Ki-67 proliferation index is an indicator of poor prognosis in gastric cancer. J Surg Oncol (2010) 1.58
Implementation of Consolidated HIS: Improving Quality and Efficiency of Healthcare. Healthc Inform Res (2010) 1.54
Analysis of the lymphatic stream to predict sentinel nodes in gastric cancer patients. Ann Surg Oncol (2013) 1.53
Active immunization against de novo hepatitis B virus infection in pediatric patients after liver transplantation. Hepatology (2003) 1.53
Laparoscopic gastrectomy for gastric cancer. Dig Surg (2013) 1.51
Molecular pathology of gastric carcinoma. Pathobiology (2011) 1.49
Hepatic resection compared to percutaneous ethanol injection for small hepatocellular carcinoma using propensity score matching. J Gastroenterol Hepatol (2007) 1.47
Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest (2002) 1.47
Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Jpn J Clin Oncol (2003) 1.46
The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation. Liver Transpl (2005) 1.45
Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. Cancer Res (2008) 1.45
Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma. Clin Cancer Res (2008) 1.41
Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum Pathol (2002) 1.41
E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis. Nat Med (2006) 1.40
Predictive factors associated with the reversibility of post-transplantation diabetes mellitus following liver transplantation. J Korean Med Sci (2009) 1.40
Management of postoperative hemorrhage after pancreatoduodenectomy. Hepatogastroenterology (2003) 1.39
Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet (2009) 1.39
Bone morphogenetic protein signaling regulates gastric epithelial cell development and proliferation in mice. Gastroenterology (2010) 1.38
Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol (2012) 1.38
Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg (2005) 1.37
Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction. Hum Pathol (2007) 1.36
Protein expression profiling and molecular classification of gastric cancer by the tissue array method. Clin Cancer Res (2007) 1.35
Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol (2003) 1.35
Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. J Clin Invest (2010) 1.35
Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma. Clin Cancer Res (2004) 1.33
Laparoscopy-assisted total gastrectomy for gastric cancer: a multicenter retrospective analysis. Surgery (2009) 1.32
Gastric Cancer Working Group report. Jpn J Clin Oncol (2010) 1.31
Clinicopathological analysis for recurrence of early gastric cancer. Jpn J Clin Oncol (2003) 1.31
Comparison of short- and long-term outcomes of laparoscopic-assisted total gastrectomy and open total gastrectomy in gastric cancer patients. Surg Endosc (2013) 1.30
Comparison of two- and three-dimensional camera systems in laparoscopic performance: a novel 3D system with one camera. Surg Endosc (2009) 1.30
Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma. Am J Pathol (2002) 1.29
Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma. Histopathology (2011) 1.29
Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy. Ann Surg (2005) 1.26
Laparoscopic total gastrectomy with D2 lymphadenectomy for advanced gastric cancer. World J Surg (2012) 1.26
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma. Cancer Biol Ther (2011) 1.26
Diagnostic accuracy of T and N stages with endoscopy, stomach protocol CT, and endoscopic ultrasonography in early gastric cancer. J Surg Oncol (2009) 1.26
Focal peliosis hepatis as a mimicker of hepatic tumors: radiological-pathological correlation. J Comput Assist Tomogr (2007) 1.25
Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Hum Pathol (2011) 1.25
Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene (2004) 1.25